The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
This report contains market size and forecasts of Injectable Anticoagulants in Global, including the following market information:
Global Injectable Anticoagulants Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Injectable Anticoagulants market was valued at 6268.4 million in 2021 and is projected to reach US$ 7205.2 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Low-Molecular-Weight Heparin (LMWH) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Anticoagulants include Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer, The Medicines Company, Aspen and Otsuka, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Anticoagulants companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Anticoagulants Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Injectable Anticoagulants Market Segment Percentages, by Type, 2021 (%)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others
Global Injectable Anticoagulants Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Injectable Anticoagulants Market Segment Percentages, by Application, 2021 (%)
VTE
ACS/MI
AF
Others
Global Injectable Anticoagulants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Injectable Anticoagulants Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Anticoagulants revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Injectable Anticoagulants revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka

LEAVE A REPLY

Please enter your comment!
Please enter your name here